跳至主要内容
临床试验/ITMCTR2026001691
ITMCTR2026001691招募中Unknown

Exploring the Brain Effect Regulation Mechanism of Acupuncture Intervention on the Preparietal Lobe-Executive Control Network in T2DM-MCI after Acupoint Sensitization Using fMRI-Based Deep Learning

Affiliated Hospital of Chinese Medicine of Guangzhou Medical University0 个研究点开始时间: 2025年1月1日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
60 至 90(—)
性别
All

入选标准

  • Inpatients and outpatients with T2DM in the Endocrinology Department of the Affiliated Zhongyi Hospital of Guangzhou Medical University
  • T2DM diagnosed and classified according to the 2022 "Chinese Guidelines for the Prevention and Treatment of Type 2 Diabetes"
  • Patients aged 60 years or older, previously diagnosed with T2DM, and currently undergoing treatment with insulin or antidiabetic medications
  • Determined as right-handed according to the Chinese handedness assessment criteria
  • Cooperate to complete clinical history collection, cognitive function assessment, and MRI examination

排除标准

  • Neurodegenerative diseases of the nervous system, brain trauma, or cerebrovascular diseases (organic brain lesions)
  • Severe dysfunction of the heart, liver, or kidneys; systemic organic diseases; or a history of cancer
  • Moderate to severe hypertension (systolic blood pressure >160 mmHg or diastolic blood pressure >100 mmHg) or hyperlipidemia
  • Pregnant or breastfeeding women
  • Participants who are uncooperative or unable to complete the study effectively during the trial
  • Any contraindications for magnetic resonance imaging (MRI), such as metal implants, metal dental fixtures, pacemakers, or claustrophobia
  • Other types of diabetes
  • Patients with damage to target organs

研究者

发起方
Affiliated Hospital of Chinese Medicine of Guangzhou Medical University

相似试验